These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 19517311
1. Asthma and COPD--SMi's Fifth Annual Conference. 20-21 April 2009, London, UK. Macauley D. IDrugs; 2009 Jun; 12(6):342-5. PubMed ID: 19517311 [Abstract] [Full Text] [Related]
5. Dual role of Toll-like receptors in asthma and chronic obstructive pulmonary disease. Bezemer GF, Sagar S, van Bergenhenegouwen J, Georgiou NA, Garssen J, Kraneveld AD, Folkerts G. Pharmacol Rev; 2012 Apr; 64(2):337-58. PubMed ID: 22407613 [Abstract] [Full Text] [Related]
6. Drug treatment for chronic obstructive pulmonary disease. Wark P. IDrugs; 2003 Sep; 6(9):874-9. PubMed ID: 12964067 [Abstract] [Full Text] [Related]
7. Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins? Walsh GM. Trends Pharmacol Sci; 2008 Jan; 29(1):6-11. PubMed ID: 18054798 [Abstract] [Full Text] [Related]
8. Chronic Obstructive Pulmonary Disease--SMi's Second Annual Conference. 10-11 March 2004, London, UK. De La Rue SA. IDrugs; 2004 Apr; 7(4):318-22. PubMed ID: 15057634 [Abstract] [Full Text] [Related]
9. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases. Blease K, Raymon HK. Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647 [Abstract] [Full Text] [Related]
10. Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient. Lessard A, Maltais F, Boulet LP. Expert Opin Pharmacother; 2008 Jan; 9(1):83-93. PubMed ID: 18076340 [Abstract] [Full Text] [Related]
11. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy. Onoue S, Misaka S, Kawabata Y, Yamada S. Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334 [Abstract] [Full Text] [Related]
12. Novel CRTH2 antagonists: a review of patents from 2006 to 2009. Ulven T, Kostenis E. Expert Opin Ther Pat; 2010 Nov; 20(11):1505-30. PubMed ID: 20946089 [Abstract] [Full Text] [Related]
14. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Krigsman K, Nilsson JL, Ring L. Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1120-8. PubMed ID: 17566142 [Abstract] [Full Text] [Related]
15. Importance of inhaler devices in the management of airway disease. Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenberg J, Barnes PJ. Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402 [Abstract] [Full Text] [Related]
16. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD. Onoue S, Yamada S, Yajima T. Peptides; 2007 Sep; 28(9):1640-50. PubMed ID: 17537541 [Abstract] [Full Text] [Related]
18. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease. McNamara PS, Smyth RL. Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163 [Abstract] [Full Text] [Related]
19. The COPD Pipeline II. Gross NJ. COPD; 2010 Feb; 7(1):76-8. PubMed ID: 20214467 [No Abstract] [Full Text] [Related]
20. Ocular Diseases & Drug Discovery--GTCbio's Inaugural Conference. 20-21 April 2009, Philadelphia, PA, USA. Boniuk V. IDrugs; 2009 Jun; 12(6):346-8. PubMed ID: 19517312 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]